| Item | Value |
|---|---|
| DrugBank ID | DB00635 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 109 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acute lymphoblastic leukemia (disease) | TxGNN Knowledge Graph |
| 2 | Trichinella spiralis infectious disease | TxGNN Knowledge Graph |
| 3 | mantle cell lymphoma | TxGNN Knowledge Graph |
| 4 | exfoliative dermatitis | TxGNN Knowledge Graph |
| 5 | pediatric systemic lupus erythematosus | TxGNN Knowledge Graph |
| 6 | granulomatous slack skin disease | TxGNN Knowledge Graph |
| 7 | primary central nervous system lymphoma | TxGNN Knowledge Graph |
| 8 | T-cell/histiocyte rich large B cell lymphoma | TxGNN Knowledge Graph |
| 9 | systemic lupus erythematosus (disease) | TxGNN Knowledge Graph |
| 10 | rheumatoid arthritis | TxGNN Knowledge Graph |
| 11 | adrenogenital syndrome | TxGNN Knowledge Graph |
| 12 | gout | TxGNN Knowledge Graph |
| 13 | parapsoriasis | TxGNN Knowledge Graph |
| 14 | angioedema | TxGNN Knowledge Graph |
| 15 | fetal erythroblastosis | TxGNN Knowledge Graph |
| 16 | multiple sclerosis | TxGNN Knowledge Graph |
| 17 | Crohn disease | TxGNN Knowledge Graph |
| 18 | juvenile arthritis due to defect in LACC1 | TxGNN Knowledge Graph |
| 19 | diffuse large B-cell lymphoma of the central nervous system | TxGNN Knowledge Graph |
| 20 | autoimmune hemolytic anemia | TxGNN Knowledge Graph |
| 21 | adrenal insufficiency | TxGNN Knowledge Graph |
| 22 | epicondylitis | TxGNN Knowledge Graph |
| 23 | congenital adrenal hyperplasia | TxGNN Knowledge Graph |
| 24 | acquired thrombocytopenia | TxGNN Knowledge Graph |
| 25 | chronic beryllium disease | TxGNN Knowledge Graph |
| 26 | juvenile idiopathic arthritis | TxGNN Knowledge Graph |
| 27 | Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly | TxGNN Knowledge Graph |
| 28 | localized pagetoid reticulosis | TxGNN Knowledge Graph |
| 29 | non-Hodgkin lymphoma | TxGNN Knowledge Graph |
| 30 | intravascular large B-cell lymphoma | TxGNN Knowledge Graph |
| 31 | atopic eczema | TxGNN Knowledge Graph |
| 32 | inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency | TxGNN Knowledge Graph |
| 33 | B-cell neoplasm | TxGNN Knowledge Graph |
| 34 | contact dermatitis | TxGNN Knowledge Graph |
| 35 | ALK-positive large B-cell lymphoma | TxGNN Knowledge Graph |
| 36 | lymphosarcoma | TxGNN Knowledge Graph |
| 37 | humoral hypercalcemia of malignancy | TxGNN Knowledge Graph |
| 38 | Diamond-Blackfan anemia | TxGNN Knowledge Graph |
| 39 | Hodgkins lymphoma | TxGNN Knowledge Graph |
| 40 | dermatitis herpetiformis | TxGNN Knowledge Graph |
| 41 | primary cutaneous T-cell non-Hodgkin lymphoma | TxGNN Knowledge Graph |
| 42 | plasmablastic lymphoma | TxGNN Knowledge Graph |
| 43 | ankylosing spondylitis | TxGNN Knowledge Graph |
| 44 | psoriasis | TxGNN Knowledge Graph |
| 45 | vasomotor rhinitis | TxGNN Knowledge Graph |
| 46 | skin disease | TxGNN Knowledge Graph |
| 47 | Stevens-Johnson syndrome | TxGNN Knowledge Graph |
| 48 | seborrheic keratosis | TxGNN Knowledge Graph |
| 49 | non-histaminic angioedema | TxGNN Knowledge Graph |
| 50 | familial nephrotic syndrome | TxGNN Knowledge Graph |
(Showing top 50 of 109 predictions)
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.